• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清 S100B 水平与白癜风患者:它是疾病活动的标志物吗?

Serum level of S100B in vitiligo patients: Is it a marker of disease activity?

机构信息

Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Assiut University, Assiut, Egypt.

Department of Medical Biochemistry, Faculty of Medicine, Assiut University, Assiut, Egypt.

出版信息

Australas J Dermatol. 2021 Feb;62(1):e67-e72. doi: 10.1111/ajd.13462. Epub 2020 Sep 20.

DOI:10.1111/ajd.13462
PMID:32951206
Abstract

BACKGROUND

Vitiligo is a chronic depigmentary skin disorder, characterised clinically by the development of white macules and or patches caused by loss of epidermal melanocytes. S100B is a dual function protein released from epidermal melanocytes in response to injury. It considered a possible marker of disease activity in both malignant melanoma and vitiligo.

AIM OF THE STUDY

To estimate the serum level of S100B level in vitiligo patients and correlate its level with disease activity and various disease parameters.

PATIENTS AND METHODS

Sixty vitiligo patients and 60 healthy volunteers as controls were included in the study. Vitiligo Area Severity Index (VASI) and Vitiligo Disease Activity (VIDA) scores were estimated for each patient. Quantitative assessment of S100B level using ELISA technique was done for all participants.

RESULTS

S100B level was significantly correlated with the presence of vitiligo (P = 0.01), while it showed no correlation with the disease activity using VASI or VIDA scores. As regards the receiver operating characteristic (ROC) curve analysis of S100B for diagnosis and discrimination of vitiligo, serum S100B showed area under the curve (AUC) of 0.781 with 73.3% sensitivity and 80% specificity.

CONCLUSION

The serum level of S100B was related to the presence of vitiligo, but its level did not show any relation to the disease activity using either VASI and VIDA scores or various disease parameters.

摘要

背景

白癜风是一种慢性色素减退性皮肤病,临床上表现为表皮黑素细胞丧失导致的白色斑片或斑块。S100B 是一种双功能蛋白,在受到损伤时从表皮黑素细胞中释放出来。它被认为是恶性黑色素瘤和白癜风疾病活动的可能标志物。

目的

评估白癜风患者血清 S100B 水平,并与疾病活动度及各种疾病参数相关联。

患者和方法

纳入 60 例白癜风患者和 60 例健康志愿者作为对照组。对每位患者进行白癜风面积严重程度指数(VASI)和白癜风疾病活动度(VIDA)评分。采用 ELISA 技术对所有参与者的 S100B 水平进行定量评估。

结果

S100B 水平与白癜风的存在显著相关(P=0.01),而与 VASI 或 VIDA 评分的疾病活动度无相关性。在 S100B 用于诊断和鉴别白癜风的受试者工作特征(ROC)曲线分析中,血清 S100B 的曲线下面积(AUC)为 0.781,灵敏度为 73.3%,特异性为 80%。

结论

S100B 血清水平与白癜风的存在有关,但与 VASI 和 VIDA 评分或各种疾病参数的疾病活动度无相关性。

相似文献

1
Serum level of S100B in vitiligo patients: Is it a marker of disease activity?血清 S100B 水平与白癜风患者:它是疾病活动的标志物吗?
Australas J Dermatol. 2021 Feb;62(1):e67-e72. doi: 10.1111/ajd.13462. Epub 2020 Sep 20.
2
Sensitivity of serum S100B protein as a disease activity marker in Egyptian patients with vitiligo (case-control study).血清 S100B 蛋白作为埃及白癜风患者疾病活动标志物的敏感性(病例对照研究)。
Arch Physiol Biochem. 2022 Aug;128(4):930-937. doi: 10.1080/13813455.2020.1739717. Epub 2020 Mar 19.
3
Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.通过邻近连接分析检测白癜风和黑色素瘤患者血清中SOX10水平升高
PLoS One. 2016 Apr 25;11(4):e0154214. doi: 10.1371/journal.pone.0154214. eCollection 2016.
4
S100B Is a Potential Disease Activity Marker in Nonsegmental Vitiligo.S100B是局限性白癜风潜在的疾病活动标志物。
J Invest Dermatol. 2017 Jul;137(7):1445-1453. doi: 10.1016/j.jid.2017.01.033. Epub 2017 Feb 14.
5
Interleukin 31 in vitiligo patients with and without pruritus.白细胞介素 31 在有瘙痒和无瘙痒的白癜风患者中的表达。
Acta Dermatovenerol Alp Pannonica Adriat. 2024 Sep;33(3):111-116.
6
Circulatory levels of alarmins in patients with non-segmental vitiligo: Potential biomarkers for disease diagnosis and activity/severity assessment.循环系统中警报素在非节段性白癜风患者中的水平:疾病诊断和活动/严重程度评估的潜在生物标志物。
Front Immunol. 2022 Dec 7;13:1069196. doi: 10.3389/fimmu.2022.1069196. eCollection 2022.
7
Study of serum levels and skin expression of S100B protein in psoriasis.银屑病患者血清S100B蛋白水平及皮肤表达的研究
An Bras Dermatol. 2017 May-Jun;92(3):323-328. doi: 10.1590/abd1806-4841.20175038.
8
Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers.精神分裂症患者血浆 S100B 浓度升高,并与炎症标志物相关。
Sci Rep. 2016 Jun 9;6:27584. doi: 10.1038/srep27584.
9
Serum S100A12 and S100B proteins are independent predictors of the presence and severity of obstructive sleep apnea.血清 S100A12 和 S100B 蛋白是阻塞性睡眠呼吸暂停存在和严重程度的独立预测因子。
Turk J Med Sci. 2019 Jun 18;49(3):746-754. doi: 10.3906/sag-1806-147.
10
The role of serum cholinesterase activity and S100B protein in the evaluation of organophosphate poisoning.血清胆碱酯酶活性和 S100B 蛋白在评估有机磷中毒中的作用。
Hum Exp Toxicol. 2013 Oct;32(10):1081-8. doi: 10.1177/0960327112474850. Epub 2013 Feb 19.

引用本文的文献

1
The role of serum S100B and serum thyroid stimulating hormone levels in vitiligo.血清S100B和血清促甲状腺激素水平在白癜风中的作用。
Arch Dermatol Res. 2025 Jan 9;317(1):217. doi: 10.1007/s00403-024-03765-9.
2
Serum Calprotectin Levels in Vitiligo Patients and Disease Relation.白癜风患者血清钙卫蛋白水平及其与疾病的关系
Dermatol Pract Concept. 2024 Jul 1;14(3):e2024184. doi: 10.5826/dpc.1403a184.
3
Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo.白癜风的临床特征、免疫发病机制与治疗策略。
Clin Rev Allergy Immunol. 2021 Dec;61(3):299-323. doi: 10.1007/s12016-021-08868-z. Epub 2021 Jul 20.
4
Morphological Alterations and Increased S100B Expression in Epidermal Langerhans Cells Detected in Skin from Patients with Progressive Vitiligo.在进展期白癜风患者皮肤中检测到的表皮朗格汉斯细胞的形态学改变及S100B表达增加
Life (Basel). 2021 Jun 18;11(6):579. doi: 10.3390/life11060579.